Key Metrics
CiteScore 

4.8
H-Index 

78
Impact Factor 

< 5
SJR 

Q2Endocrinology

SNIP 

1.35
Recommended pre-submission checks
Powered by 

Topics Covered on Current Opinion in Endocrinology, Diabetes and Obesity
Current Opinion in Endocrinology, Diabetes and Obesity Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Opinion in Endocrinology, Diabetes and Obesity ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Opinion in Endocrinology, Diabetes and Obesity
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
New horizons for autoimmune hyperthyroidism with FcRn blockers.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Exploring the role of parathyroid hormone in sarcopenia: A review.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
EDITORIAL INTRODUCTION.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
New horizons for autoimmune hyperthyroidism with FcRn blockers.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Exploring the role of parathyroid hormone in sarcopenia: A review.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
EDITORIAL INTRODUCTION.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
FAQs on Current Opinion in Endocrinology, Diabetes and Obesity
How long has Current Opinion in Endocrinology, Diabetes and Obesity been actively publishing? 
What is the publishing frequency of Current Opinion in Endocrinology, Diabetes and Obesity? 
How many articles did Current Opinion in Endocrinology, Diabetes and Obesity publish last year? 
What is the eISSN & pISSN for Current Opinion in Endocrinology, Diabetes and Obesity? 
What is Citescore for Current Opinion in Endocrinology, Diabetes and Obesity? 
What is the H Index for Current Opinion in Endocrinology, Diabetes and Obesity ? 
What is SNIP score for Current Opinion in Endocrinology, Diabetes and Obesity? 
What is the SJR for Current Opinion in Endocrinology, Diabetes and Obesity? 
Who is the publisher of Current Opinion in Endocrinology, Diabetes and Obesity? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary